Multisignal labeling reagents and processes and uses therefor

US9884889B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9884889-B2
Application numberUS-201514844468-A
CountryUS
Kind codeB2
Filing dateSep 3, 2015
Priority dateApr 3, 2003
Publication dateFeb 6, 2018
Grant dateFeb 6, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are compounds comprising two DNA supramolecular binding molecules covalently joined by a linker group. Also provided are multisignal labeling reagents comprising (i) an oligomer of nucleotides or nucleotide analogs; (ii) a DNA supramolecular binding molecule noncovalently bound to the oligomer; and (iii) a first reactive group or a first partner of a first binding pair covalently bound to the oligomer. Additionally provided are methods of producing multisignal labeling reagents.

First claim

Opening claim text (preview).

What is claimed is: 1. A multisignal labeling reagent comprising: (i) an oligomer of nucleotides or nucleotide analogs; (ii) a plurality of DNA supramolecular binding molecules noncovalently bound to the oligomer, wherein said DNA supramolecular binding molecules comprise a detectable label attached thereto that is not a DNA supramolecular binding molecule, and wherein said DNA supramolecular binding molecules are selected from minor groove binders and major groove binders; and (iii) a first reactive group covalently bound to the oligomer, or a first partner of a first binding pair covalently bound to the oligomer. 2. The multisignal labeling reagent of claim 1 , wherein the DNA supramolecular binding molecule is fluorescent. 3. The multisignal labeling reagent of claim 1 , wherein the detectable label is non-radioactive. 4. The multisignal labeling reagent of claim 3 , wherein the non-radioactive detectable label is a fluorophore. 5. The multisignal labeling reagent of claim 3 , wherein the non-radioactive detectable label is a chemiluminescent or phosphorescent moiety. 6. The multisignal labeling reagent of claim 1 , wherein the DNA supramolecular binding molecules comprise DNA supramolecular binding molecules which are minor groove binders. 7. The multisignal labeling reagent of claim 6 , wherein the minor groove binders comprise a minor groove binder selected from the group consisting of a diacrylamidine and a bis-benzimidazole. 8. The multisignal labeling reagent of claim 6 , wherein the minor groove binders comprise a minor groove binder selected from the group consisting of DAPI, berenil, pentamidine, distamycin A, and Hoechst 33258. 9. The multisignal labeling reagent of claim 1 , wherein the DNA supramolecular binding molecules comprise DNA supramolecular binding molecules which are major groove binders. 10. The multisignal labeling reagent of claim 9 , wherein the major groove binders comprise a major groove binder selected from the group consisting of a zinc finger, a leucine zipper, and a helix-turn-helix motif. 11. The multisignal labeling reagent of claim 1 , comprising the first partner of the first binding pair covalently bound to the oligomer. 12. The multisignal labeling reagent of claim 11 , wherein the first binding pair is a ligand/receptor, a hormone/receptor, biotin/avidin, biotin/streptavidin or an antigen/antibody binding pair. 13. The multisignal labeling reagent of claim 11 , wherein the first partner of the first binding pair is streptavidin. 14. The multisignal labeling reagent of claim 1 , comprising the first reactive group covalently bound to the oligomer.

Assignees

Inventors

Classifications

  • Coumarine dyes · CPC title

  • C07H21/00Primary

    Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids · CPC title

  • in which the condensed system contains four or more hetero rings · CPC title

  • with fluorescent label · CPC title

  • Nitrogen atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9884889B2 cover?
Provided are compounds comprising two DNA supramolecular binding molecules covalently joined by a linker group. Also provided are multisignal labeling reagents comprising (i) an oligomer of nucleotides or nucleotide analogs; (ii) a DNA supramolecular binding molecule noncovalently bound to the oligomer; and (iii) a first reactive group or a first partner of a first binding pair covalently bound…
Who is the assignee on this patent?
Enzo Life Science Inc, Enzo Life Sciences Inc
What technology area does this patent fall under?
Primary CPC classification C07H21/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).